Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Daebong Ls Ltd. operates within the Biotechnology & Pharmaceuticals technology area and currently has 1 pending office action. This activity is concentrated in the distinct art units identified in the data, which suggests a focused prosecution strategy for the company's current intellectual property. By maintaining its filings within the specified art unit, the company can streamline its responses to meet the technical standards of that USPTO division.
The prosecution of this portfolio is handled by the distinct examiners listed, including IANNUZO, NATALIE NMN. This individual is the busiest examiner for the company and has a busiest examiner pending count of 1. Since the busiest examiner workload represents the entirety of the company's pending office actions, the prosecution is centralized under this single official. This means that the company's success in the Biotechnology & Pharmaceuticals sector is closely tied to the examination patterns of IANNUZO, NATALIE NMN.
The presence of the specified examiner and art unit indicates a highly focused prosecution environment. Practitioners can concentrate their efforts on the requirements and feedback of the assigned examiner rather than managing multiple different prosecution tracks. The current objective for Daebong Ls Ltd. is to resolve the pending action and advance its interests within the specified field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IANNUZO, NATALIE NMN | 1 | 12.5% | +71.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17773220 | COMPOSITION COMPRISING THE EXTRACT OF TREMELLA FUCIFORMIS CULTURE MEDIUM | IANNUZO, NATALIE NMN | 22d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17773220 | COMPOSITION COMPRISING THE EXTRACT OF TREMELLA FUCIFORMIS CULTURE MEDIUM | IANNUZO, NATALIE NMN | 22d |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17773220 | COMPOSITION COMPRISING THE EXTRACT OF TREMELLA FUCIFORMIS CULTURE MEDIUM | IANNUZO, NATALIE NMN | 1653 | §101§103§112 | Non-Final OA | 22d | Pending | Apr 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial